Biocatalytic Synthesis of Ruxolitinib Intermediate via Engineered Imine Reductase.
J Org Chem
; 89(16): 11446-11454, 2024 08 16.
Article
em En
| MEDLINE
| ID: mdl-39113180
ABSTRACT
An enzyme catalyzed strategy for the synthesis of a chiral hydrazine from 3-cyclopentyl-3-oxopropanenitrile 5 and hydrazine hydrate 2 is presented. An imine reductase (IRED) from Streptosporangium roseum was identified to catalyze the reaction between 3-cyclopentyl-3-oxopropanenitrile 5 and hydrazine hydrate 2 to produce trace amounts of (R)-3-cyclopentyl-3-hydrazineylpropanenitrile 4. We employed a 2-fold approach to optimize the catalytic performance of this enzyme. First, a transition state analogue (TSA) model was constructed to illuminate the enzyme-substrate interactions. Subsequently, the Enzyme_design and Funclib methods were utilized to predict mutants for experimental evaluation. Through three rounds of site-directed mutagenesis, site saturation mutagenesis, and combinatorial mutagenesis, we obtained mutant M6 with a yield of 98% and an enantiomeric excess (ee) of 99%. This study presents an effective method for constructing a hydrazine derivative via IRED-catalyzed reductive amination of ketone and hydrazine. Furthermore, it provides a general approach for constructing suitable enzymes, starting from nonreactive enzymes and gradually enhancing their catalytic activity through active site modifications.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Oxirredutases
/
Pirazóis
/
Pirimidinas
/
Biocatálise
/
Nitrilas
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article